- Home
- AUTL vs OMI Comparison
AUTL vs OMI Comparison
Compare AUTL & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | OMI |
|---|---|---|
| Founded | 2014 | 1882 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 415.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | OMI |
|---|---|---|
| Price | $1.55 | $2.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $8.33 | $6.46 |
| AVG Volume (30 Days) | ★ 3.9M | 1.8M |
| Earning Date | 11-12-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $51,128,000.00 | ★ $10,768,859,000.00 |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | 132.03 |
| 52 Week Low | $1.11 | $2.45 |
| 52 Week High | $3.11 | $15.54 |
Technical Indicators
Market Signals| Indicator | AUTL | OMI |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 27.59 |
| Support Level | $1.31 | $2.45 |
| Resistance Level | $1.61 | $2.84 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 85.37 | 25.23 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.